Anticoagulant / blödning

Hemorrhagic-lesion producing and anticoagulant-containing compositions and their use

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Rats, e.g., have particularly good memories and a relatively high intelligence quotient. They are able to connect the toxic effect of rapidly-acting poisons with the type and position of employed bait, and they warn other rats. Rodenticides comprising anti-coagulating or

Preparation of low bleeding anticoagulant fusion protein and its use

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

This application is a 371 of PCT/CN07/03526, filed Dec. 11, 2007, which claims priority to Chinese patent application 200610165756.7, filed Dec. 16, 2006. FIELD OF INVENTION This invention belongs to the area of biotechnology, and relates to structure and preparation of a kind of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The entire content of all above applications is incorporated herein by reference. BACKGROUND OF INVENTION a. Field of Invention The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent

Modified serpins for the treatment of bleeding disorders

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

SEQUENCE LISTING The instant application contains a Sequence Listing (.txt file named Sequence_Listing, having a date of May 4, 2018 and 63,944 bytes in size) which has been submitted in ASCII format via EFS-Web and is incorporated by reference herein. FIELD This invention relates to modified serpin

Modified serpins for the treatment of bleeding disorders

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD This invention relates to modified serpin molecules with altered specificity, in particular serpin molecules modified to have increased specificity for anticoagulant proteases, such as activated Protein C (APC). BACKGROUND Hemophilias are bleeding disorders, which are caused by a deficiency in

Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/IB2008/000945, filed on Apr. 18, 2008, which claims the benefit of U.S. Provisional Application No. 60/907,875, filed on Apr. 20, 2007, the entire contents of which are herein

Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The invention relates to treatment and prevention of a certain form of shock, hypovolemic shock and related syndromes with substantially non-anticoagulant chemically modified heparinoids. The heparinoids preserve the function of heart, liver, kidney and gut, protect

Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The invention relates to treatment and prevention of a certain form of shock, hypovolemic shock and related syndromes with substantially non-anticoagulant chemically modified heparinoids. The heparinoids preserve the function of heart, liver, kidney and gut, protect

Methods for treating bleeding disorders using sulfated polysaccharides

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TECHNICAL FIELD This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)

anticoagulant/blödning

Hemorrhagic-lesion producing and anticoagulant-containing compositions and their use

Preparation of low bleeding anticoagulant fusion protein and its use

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Modified serpins for the treatment of bleeding disorders

Modified serpins for the treatment of bleeding disorders

Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding

Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes

Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes

Methods for treating bleeding disorders using sulfated polysaccharides

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen